StreetInsider.com News Articles

Form 4 Avalo Therapeutics, Inc. For: Aug 17 Filed by: Sullivan Christopher Ryan

Tue, 25 Aug 2026 19:03:00 -0400

si-local-file:///var/storage/secattach/20260825/26975956.html

Form 4 Avalo Therapeutics, Inc. For: Aug 17 Filed by: Doyle Mittie

Tue, 25 Aug 2026 19:03:00 -0400

si-local-file:///var/storage/secattach/20260825/26975991.html

Form 4 Avalo Therapeutics, Inc. For: Aug 17 Filed by: Sullivan Christopher Ryan

Wed, 19 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260819/26950140.html

Form 4 Avalo Therapeutics, Inc. For: Aug 17 Filed by: Doyle Mittie

Wed, 19 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260819/26950142.html

Form 144 Avalo Therapeutics, Inc. Filed by: Sullivan Christopher Ryan

Tue, 18 Aug 2026 16:18:00 -0400

si-local-file:///var/storage/secattach/20260818/26944529.html

Form 144 Avalo Therapeutics, Inc. Filed by: Doyle Mittie

Mon, 17 Aug 2026 16:49:00 -0400

si-local-file:///var/storage/secattach/20260817/26938630.html

Form 144 Avalo Therapeutics, Inc. Filed by: Sullivan Christopher Ryan

Mon, 17 Aug 2026 16:48:00 -0400

si-local-file:///var/storage/secattach/20260817/26938602.html

Form 144 Avalo Therapeutics, Inc. Filed by: Sullivan Christopher Ryan

Mon, 17 Aug 2026 16:18:00 -0400

si-local-file:///var/storage/secattach/20260817/26938191.html

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Nantahala Capital Management, LLC

Fri, 14 Aug 2026 16:49:00 -0400

si-local-file:///var/storage/secattach/20260814/26932190.html

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Fri, 14 Aug 2026 16:48:00 -0400

si-local-file:///var/storage/secattach/20260814/26932089.html

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Caligan Partners LP

Fri, 14 Aug 2026 16:48:00 -0400

si-local-file:///var/storage/secattach/20260814/26932122.html

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P

Fri, 14 Aug 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260814/26929957.html

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: T. Rowe Price Investment Management, Inc.

Fri, 14 Aug 2026 10:40:00 -0400

si-local-file:///var/storage/secattach/20260814/26926666.html

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Avoro Capital Advisors LLC

Fri, 14 Aug 2026 09:01:00 -0400

si-local-file:///var/storage/secattach/20260814/26925531.html

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Deep Track Capital, LP

Fri, 14 Aug 2026 08:25:00 -0400

si-local-file:///var/storage/secattach/20260814/26925044.html

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Affinity Asset Advisors, LLC

Thu, 13 Aug 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260813/26920952.html

Form 4 Avalo Therapeutics, Inc. For: Aug 10 Filed by: Doyle Mittie

Wed, 12 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260812/26912923.html

Form 4 Avalo Therapeutics, Inc. For: Aug 11 Filed by: Riley Jennifer

Wed, 12 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260812/26912929.html

Form 144 Avalo Therapeutics, Inc. Filed by: Riley Jennifer

Tue, 11 Aug 2026 16:23:00 -0400

si-local-file:///var/storage/secattach/20260811/26906158.html

Form 144 Avalo Therapeutics, Inc. Filed by: Doyle Mittie

Mon, 10 Aug 2026 16:48:00 -0400

si-local-file:///var/storage/secattach/20260810/26898816.html

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: FMR LLC

Fri, 07 Aug 2026 11:05:00 -0400

si-local-file:///var/storage/secattach/20260807/26889278.html

Form SCHEDULE 13G Avalo Therapeutics, Inc. Filed by: STATE STREET CORP

Fri, 07 Aug 2026 08:57:00 -0400

si-local-file:///var/storage/secattach/20260807/26888216.html

Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: FMR LLC

Thu, 06 Aug 2026 10:15:00 -0400

si-local-file:///var/storage/secattach/20260806/26881015.html

Avalo Therapeutics Inc. (AVTX) PT Lowered to $48 at Guggenheim

Thu, 06 Aug 2026 09:50:44 -0400

Guggenheim analyst Yatin Suneja lowered the price target on Avalo Therapeutics Inc. (NASDAQ: AVTX) to $48.00 (from $50.00) while maintaining a Buy rating.

Avalo Therapuetics (AVTX) Misses Q2 EPS by 25c

Thu, 06 Aug 2026 07:47:02 -0400

Avalo Therapuetics (NASDAQ: AVTX) reported Q2 EPS of ($0.83), $0.25 worse than the analyst estimate of ($0.58).

For earnings history and earnings-related data on Avalo Therapuetics (AVTX) click here.